Form 8-K - Current report:
SEC Accession No. 0001493152-25-001841
Filing Date
2025-01-13
Accepted
2025-01-13 06:04:47
Documents
61
Period of Report
2025-01-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38614
2 ex99-1.htm EX-99.1 44678
3 form8-k_001.jpg GRAPHIC 5681
4 ex99-1_001.jpg GRAPHIC 623529
5 ex99-1_002.jpg GRAPHIC 1168149
6 ex99-1_003.jpg GRAPHIC 961212
7 ex99-1_004.jpg GRAPHIC 963857
8 ex99-1_005.jpg GRAPHIC 553386
9 ex99-1_006.jpg GRAPHIC 949223
10 ex99-1_007.jpg GRAPHIC 853762
11 ex99-1_008.jpg GRAPHIC 903287
12 ex99-1_009.jpg GRAPHIC 933006
13 ex99-1_010.jpg GRAPHIC 928931
14 ex99-1_011.jpg GRAPHIC 685009
15 ex99-1_012.jpg GRAPHIC 530778
16 ex99-1_013.jpg GRAPHIC 1201841
17 ex99-1_014.jpg GRAPHIC 1130882
18 ex99-1_015.jpg GRAPHIC 1165561
19 ex99-1_016.jpg GRAPHIC 1061388
20 ex99-1_017.jpg GRAPHIC 635084
21 ex99-1_018.jpg GRAPHIC 547654
22 ex99-1_019.jpg GRAPHIC 733166
23 ex99-1_020.jpg GRAPHIC 925385
24 ex99-1_021.jpg GRAPHIC 833064
25 ex99-1_022.jpg GRAPHIC 600823
26 ex99-1_023.jpg GRAPHIC 1362857
27 ex99-1_024.jpg GRAPHIC 768106
28 ex99-1_025.jpg GRAPHIC 1005473
29 ex99-1_026.jpg GRAPHIC 869665
30 ex99-1_027.jpg GRAPHIC 380184
31 ex99-1_028.jpg GRAPHIC 670275
32 ex99-1_029.jpg GRAPHIC 809455
33 ex99-1_030.jpg GRAPHIC 1053756
34 ex99-1_031.jpg GRAPHIC 332045
35 ex99-1_032.jpg GRAPHIC 835145
36 ex99-1_033.jpg GRAPHIC 1132991
37 ex99-1_034.jpg GRAPHIC 669758
38 ex99-1_035.jpg GRAPHIC 721812
39 ex99-1_036.jpg GRAPHIC 976373
40 ex99-1_037.jpg GRAPHIC 939767
41 ex99-1_038.jpg GRAPHIC 749853
42 ex99-1_039.jpg GRAPHIC 603765
43 ex99-1_040.jpg GRAPHIC 936961
44 ex99-1_041.jpg GRAPHIC 1002447
45 ex99-1_042.jpg GRAPHIC 551607
46 ex99-1_043.jpg GRAPHIC 1122365
47 ex99-1_044.jpg GRAPHIC 874211
48 ex99-1_045.jpg GRAPHIC 702980
49 ex99-1_046.jpg GRAPHIC 738267
  Complete submission text file 0001493152-25-001841.txt   53479903

Data Files

Seq Description Document Type Size
50 XBRL SCHEMA FILE lpcn-20250113.xsd EX-101.SCH 3015
51 XBRL LABEL FILE lpcn-20250113_lab.xml EX-101.LAB 34240
52 XBRL PRESENTATION FILE lpcn-20250113_pre.xml EX-101.PRE 24165
63 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3685
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 25524631
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)